HemaSphere
(Jun 2022)
P1649: GFI1B AND LSD1 REPRESS A MYELOID DIFFERENTIATION PROGRAM DURING INDUCED PLURIPOTENT STEM CELL DERIVED MEGAKARYOCYTE DIFFERENTIATION
- J. Venhuizen,
- M. van Bergen,
- D. Gilissen,
- L. Wingens,
- E. van den Akker,
- J. Jansen,
- J. Martens,
- B. van der Reijden
Affiliations
- J. Venhuizen
- 1 Department of Laboratory Medicine, Laboratory of Hematology, RadboudUMC
- M. van Bergen
- 1 Department of Laboratory Medicine, Laboratory of Hematology, RadboudUMC
- D. Gilissen
- 1 Department of Laboratory Medicine, Laboratory of Hematology, RadboudUMC
- L. Wingens
- 2 Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Nijmegen
- E. van den Akker
- 3 Department of Hematopoiesis, Sanquin Research, Amsterdam, Netherlands
- J. Jansen
- 1 Department of Laboratory Medicine, Laboratory of Hematology, RadboudUMC
- J. Martens
- 2 Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Nijmegen
- B. van der Reijden
- 1 Department of Laboratory Medicine, Laboratory of Hematology, RadboudUMC
- DOI
-
https://doi.org/10.1097/01.HS9.0000849452.15153.0f
- Journal volume & issue
-
Vol. 6
pp.
1530
– 1531
WeChat QR code